{
    "2019-02-14": [
        [
            {
                "time": "2019-02-14",
                "original_text": "Is Johnson & Johnson CEO Alex Gorsky Earning His Pay?",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "CEO",
                        "Alex Gorsky"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-02-14",
                "original_text": "Veracyte CEO navigated early troubles, now has her company on path to growth",
                "features": {
                    "keywords": [
                        "Veracyte",
                        "CEO",
                        "growth"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-02-14",
                "original_text": "Johnson & Johnson (JNJ) to Acquire Auris Health for $3.4B",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Acquire",
                        "Auris Health"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-02-14",
                "original_text": "Bayer stresses drug's tolerability in bid for prostate cancer market",
                "features": {
                    "keywords": [
                        "Bayer",
                        "drug",
                        "prostate cancer"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-02-14",
                "original_text": "10 Hot Stocks Leading the Market’s Blitz Higher",
                "features": {
                    "keywords": [
                        "Hot Stocks",
                        "Market",
                        "Blitz Higher"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-02-14",
                "original_text": "FDA Panel Nod for J&J's Esketamine Is Good News for Allergan, Vistagen",
                "features": {
                    "keywords": [
                        "FDA",
                        "Esketamine",
                        "Allergan",
                        "Vistagen"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-02-14",
                "original_text": "Johnson & Johnson to Participate in the 8th Annual SVB Leerink Global Healthcare Conference",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "SVB Leerink",
                        "Healthcare Conference"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-02-14",
                "original_text": "Did Johnson & Johnson Just Spit in Alphabet's Face?",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Alphabet"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "technology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-02-14",
                "original_text": "Health Care Sector Update for 02/14/2019: MTFB, MDGS, INO, JNJ, PFE, MRK, ABT, AMGN",
                "features": {
                    "keywords": [
                        "Health Care Sector",
                        "MTFB",
                        "MDGS",
                        "INO",
                        "JNJ",
                        "PFE",
                        "MRK",
                        "ABT",
                        "AMGN"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-02-14",
                "original_text": "[$$] J&J and Novartis back cancer geneticist’s immunotherapy start-up",
                "features": {
                    "keywords": [
                        "J&J",
                        "Novartis",
                        "cancer",
                        "immunotherapy"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-02-14",
                "original_text": "[$$] Johnson & Johnson to Buy Surgical Robotics Maker",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Surgical Robotics"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}